NCT02541591View on ClinicalTrials.gov

Neuroprotective Goal Directed Hemodynamic Optimization in Post-cardiac Arrest Patients

NACompletedINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

June 30, 2018

Study Completion Date

June 30, 2018

Conditions
Cerebral IschemiaCardiac Arrest
Interventions
OTHER

Neuroprotective goal directed hemodynamic optimization

OTHER

MAP > 65mmHg

MAP \> 65mmHg

Trial Locations (2)

3000

UZ Leuven, Leuven

3600

Ziekenhuis Oost Limburg, Genk

All Listed Sponsors
collaborator

Ziekenhuis Oost-Limburg

OTHER

lead

Universitaire Ziekenhuizen KU Leuven

OTHER

NCT02541591 - Neuroprotective Goal Directed Hemodynamic Optimization in Post-cardiac Arrest Patients | Biotech Hunter | Biotech Hunter